Renewal of Cellular, Tissue, and Gene Therapies Advisory Committee
The FDA announced the two-year charter renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee.
The FDA announced the two-year charter renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee.